These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36997082)

  • 1. Vaccination of squirrel monkeys (Saimiri spp.) with nanoparticle-based Toxoplasma gondii antigens: new hope for captive susceptible species.
    Ducournau C; Cantin P; Alerte V; Quintard B; Popelin-Wedlarski F; Wedlarski R; Ollivet-Courtois F; Ferri-Pisani Maltot J; Herkt C; Fasquelle F; Sannier M; Berthet M; Fretay V; Aubert D; Villena I; Betbeder D; Moiré N; Dimier-Poisson I
    Int J Parasitol; 2023 Jun; 53(7):333-346. PubMed ID: 36997082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outbreak of toxoplasmosis in four squirrel monkeys (Saimiri sciureus) in Japan.
    Nishimura M; Goyama T; Tomikawa S; Fereig RM; El-Alfy EN; Nagamune K; Kobayashi Y; Nishikawa Y
    Parasitol Int; 2019 Feb; 68(1):79-86. PubMed ID: 30347233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective Nanoparticle-Based Nasal Vaccine Against Latent and Congenital Toxoplasmosis in Sheep.
    Ducournau C; Moiré N; Carpentier R; Cantin P; Herkt C; Lantier I; Betbeder D; Dimier-Poisson I
    Front Immunol; 2020; 11():2183. PubMed ID: 33013917
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis.
    Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Grzybowski M; Dlugonska H
    Vaccine; 2011 Jan; 29(4):821-30. PubMed ID: 21087690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma Gondii is a novel vaccine candidate against toxoplasmosis in mice.
    Zheng B; Lu S; Tong Q; Kong Q; Lou D
    Vaccine; 2013 Sep; 31(41):4578-84. PubMed ID: 23928460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and molecular characterization of Toxoplasma gondii in a colony of captive black-capped squirrel monkeys (Saimiri boliviensis).
    Pardini L; Dellarupe A; Bacigalupe D; Quiroga MA; Moré G; Rambeaud M; Basso W; Unzaga JM; Schares G; Venturini MC
    Parasitol Int; 2015 Dec; 64(6):587-90. PubMed ID: 26299363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasal vaccination of six squirrel monkeys (
    Fasquelle F; Scuotto A; Vreulx AC; Petit T; Charpentier T; Betbeder D
    Int J Parasitol Parasites Wildl; 2023 Dec; 22():69-74. PubMed ID: 37720360
    [No Abstract]   [Full Text] [Related]  

  • 8. Protective efficacy induced by DNA prime and recombinant protein boost vaccination with Toxoplasma gondii GRA14 in mice.
    Pagheh AS; Sarvi S; Gholami S; Asgarian-Omran H; Valadan R; Hassannia H; Ahmadpour E; Fasihi-Ramandie M; Dodangeh S; Hosseni-Khah Z; Daryani A
    Microb Pathog; 2019 Sep; 134():103601. PubMed ID: 31212035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plant Hsp90 is a novel adjuvant that elicits a strong humoral and cellular immune response against B- and T-cell epitopes of a Toxoplasma gondii SAG1 peptide.
    Sánchez-López EF; Corigliano MG; Albarracín RM; Sander VA; Legarralde A; Bengoa-Luoni SA; Clemente M
    Parasit Vectors; 2019 Mar; 12(1):140. PubMed ID: 30909938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxoplasma gondii: Vaccination with a DNA vaccine encoding T- and B-cell epitopes of SAG1, GRA2, GRA7 and ROP16 elicits protection against acute toxoplasmosis in mice.
    Cao A; Liu Y; Wang J; Li X; Wang S; Zhao Q; Cong H; He S; Zhou H
    Vaccine; 2015 Nov; 33(48):6757-62. PubMed ID: 26518401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of Immune Responses Elicited by Adjuvanted Tachyzoite Lysate Vaccines Developed from Two Different Toxoplasma gondii Strains Isolated in Turkey].
    Polat C; Gülçe İz S; Döşkaya M; Can H; Caner A; Değirmenci A; Balcan E; Gürüz Y
    Mikrobiyol Bul; 2013 Jan; 47(1):122-34. PubMed ID: 23390909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological evaluation of a DNA cocktail vaccine with co-delivery of calcium phosphate nanoparticles (CaPNs) against the Toxoplasma gondii RH strain in BALB/c mice.
    Rahimi MT; Sarvi S; Sharif M; Abediankenari S; Ahmadpour E; Valadan R; Ramandie MF; Hosseini SA; Daryani A
    Parasitol Res; 2017 Feb; 116(2):609-616. PubMed ID: 27909791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination with Toxoplasma gondii calcium-dependent protein kinase 6 and rhoptry protein 18 encapsulated in poly(lactide-co-glycolide) microspheres induces long-term protective immunity in mice.
    Zhang NZ; Xu Y; Wang M; Chen J; Huang SY; Gao Q; Zhu XQ
    BMC Infect Dis; 2016 Apr; 16():168. PubMed ID: 27090890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effect of GRA7 and profilin proteins in vaccination against chronic Toxoplasma gondii infection.
    Arcon N; Picchio MS; Fenoy IM; Moretta RE; Soto AS; Perrone Sibilia MD; Sánchez VR; Prato CA; Tribulatti MV; Goldman A; Martin V
    Vaccine; 2021 Feb; 39(6):933-942. PubMed ID: 33451777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxoplasma gondii: the vaccine potential of three trivalent antigen-cocktails composed of recombinant ROP2, ROP4, GRA4 and SAG1 proteins against chronic toxoplasmosis in BALB/c mice.
    Dziadek B; Gatkowska J; Grzybowski M; Dziadek J; Dzitko K; Dlugonska H
    Exp Parasitol; 2012 May; 131(1):133-8. PubMed ID: 22445587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of protective immune responses induced by DNA vaccines encoding Toxoplasma gondii surface antigen 1 (SAG1) and 14-3-3 protein in BALB/c mice.
    Meng M; He S; Zhao G; Bai Y; Zhou H; Cong H; Lu G; Zhao Q; Zhu XQ
    Parasit Vectors; 2012 Nov; 5():273. PubMed ID: 23181694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination with recombinant adenoviruses expressing Toxoplasma gondii MIC3, ROP9, and SAG2 provide protective immunity against acute toxoplasmosis in mice.
    Zhang D; Jiang N; Chen Q
    Vaccine; 2019 Feb; 37(8):1118-1125. PubMed ID: 30670302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of immune responses by vaccine potential of three antigens, including ROP18, MIC4, and SAG1 against acute toxoplasmosis in mice.
    Nayeri T; Sarvi S; Fasihi-Ramandi M; Valadan R; Asgarian-Omran H; Ajami A; Khalilian A; Hosseininejad Z; Dodangeh S; Javidnia J; Daryani A
    Exp Parasitol; 2023 Jan; 244():108427. PubMed ID: 36379272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of protective immunity induced by DNA vaccination with genes encoding Toxoplasma gondii GRA17 and GRA23 against acute toxoplasmosis in mice.
    Zhu WN; Wang JL; Chen K; Yue DM; Zhang XX; Huang SY; Zhu XQ
    Exp Parasitol; 2017 Aug; 179():20-27. PubMed ID: 28625894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination with recombinant adenovirus expressing multi-stage antigens of Toxoplasma gondii by the mucosal route induces higher systemic cellular and local mucosal immune responses than with other vaccination routes.
    Wang T; Yin H; Li Y; Zhao L; Sun X; Cong H
    Parasite; 2017; 24():12. PubMed ID: 28367800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.